What is Antibiotic Prophylaxis?
Antibiotic prophylaxis is the pre-emptive administration of antimicrobials to prevent infection in patients who are not yet infected but are at elevated risk due to planned procedures, immunocompromised states, or specific exposures. The goal is to achieve adequate tissue/serum drug concentration before bacterial contamination occurs.
Timing
Administer 30–60 min before incision. Vancomycin/fluoroquinolones: begin 120 min before. Repeat if surgery >2 half-lives or blood loss >1500 mL.
Spectrum
Target the most likely pathogens for the procedure site. Narrow-spectrum preferred. Broad empiric cover is NOT prophylaxis.
Duration
Single dose or ≤24 hours post-op for most surgical prophylaxis. Cardiac surgery: up to 48h. Longer ≠ better and increases resistance.
Core Principles (ASHP/IDSA/WHO)
Indication must be evidence-based. Not all surgeries require prophylaxis — Clean (Class I) wounds have SSI rates <2% without prophylaxis. Prophylaxis is indicated for clean-contaminated (Class II), implant/prosthesis surgery, and high-risk patients.
Correct drug at the correct dose. Weight-based dosing: Cefazolin 2g (3g if ≥120 kg). Underdosing in obese patients is the #1 modifiable failure point.
Redosing intraoperatively. Redose at 2× the half-life of the drug (Cefazolin q4h intra-op; Cefoxitin q2h). Also redose for significant blood loss (>1500 mL).
Discontinue promptly. Extended prophylaxis beyond 24h does NOT reduce SSI rates but DOES increase C. difficile risk, resistance emergence, and drug-related adverse events.
Consider local antibiogram. If institutional MRSA rates >10–20% for the specific procedure, add Vancomycin to (not replace) standard prophylaxis.
Surgical Wound Classification & SSI Risk
| Class | Type | SSI Rate | Prophylaxis? |
|---|---|---|---|
| I | Clean | 1–3% | Only if implant/prosthesis |
| II | Clean-Contaminated | 3–11% | Yes — Recommended |
| III | Contaminated | 10–17% | Yes → Treatment |
| IV | Dirty/Infected | >27% | Treatment (not prophylaxis) |